180 related articles for article (PubMed ID: 22367691)
1. Alternative reliable method for cytochrome P450 2D6 poor metabolizers genotyping.
Pindurová E; Zourková A; Zrůstová J; Juřica J; Pavelka A
Mol Biotechnol; 2013 Jan; 53(1):29-40. PubMed ID: 22367691
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population.
Griese EU; Zanger UM; Brudermanns U; Gaedigk A; Mikus G; Mörike K; Stüven T; Eichelbaum M
Pharmacogenetics; 1998 Feb; 8(1):15-26. PubMed ID: 9511177
[TBL] [Abstract][Full Text] [Related]
3. Developing and Evaluating the HRM Technique for Identifying Cytochrome P450 2D6 Polymorphisms.
Lu HC; Chang YS; Chang CC; Lin CH; Chang JG
J Clin Lab Anal; 2015 May; 29(3):220-5. PubMed ID: 24798984
[TBL] [Abstract][Full Text] [Related]
4. Direct assessment of cytochrome P450 2D6 genotypes by high-resolution melting analysis and DNA sequencing.
Chang YS; Lee CC; Liu TY; Chen YC; Lu HC; Chang JG
Environ Toxicol Pharmacol; 2014 Nov; 38(3):821-8. PubMed ID: 25461541
[TBL] [Abstract][Full Text] [Related]
5. Identification of CYP2D6 alleles by single nucleotide polymorphism analysis using pyrosequencing.
Zackrisson AL; Lindblom B
Eur J Clin Pharmacol; 2003 Oct; 59(7):521-6. PubMed ID: 13680033
[TBL] [Abstract][Full Text] [Related]
6. A novel intronic mutation, 2988G>A, with high predictivity for impaired function of cytochrome P450 2D6 in white subjects.
Raimundo S; Toscano C; Klein K; Fischer J; Griese EU; Eichelbaum M; Schwab M; Zanger UM
Clin Pharmacol Ther; 2004 Aug; 76(2):128-38. PubMed ID: 15289790
[TBL] [Abstract][Full Text] [Related]
7. The cytochrome P450 2D6 (CYP2D6) gene polymorphism among breast and head and neck cancer patients.
Topić E; Stefanović M; Ivanisević AM; Petrinović R; Curcić I
Clin Chim Acta; 2000 Jun; 296(1-2):101-9. PubMed ID: 10807974
[TBL] [Abstract][Full Text] [Related]
8. Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events.
Toscano C; Klein K; Blievernicht J; Schaeffeler E; Saussele T; Raimundo S; Eichelbaum M; Schwab M; Zanger UM
Pharmacogenet Genomics; 2006 Oct; 16(10):755-66. PubMed ID: 17001295
[TBL] [Abstract][Full Text] [Related]
9. A rapid multiplex PCR assay that can reliably discriminate the cytochrome P450 2D6 whole-gene deletion allele from 2D6*10 alleles.
Okubo M; Murayama N; Miura J; Shimizu M; Yamazaki H
Clin Chim Acta; 2012 Oct; 413(19-20):1675-7. PubMed ID: 22634574
[TBL] [Abstract][Full Text] [Related]
10. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.
Aynacioglu AS; Sachse C; Bozkurt A; Kortunay S; Nacak M; Schröder T; Kayaalp SO; Roots I; Brockmöller J
Clin Pharmacol Ther; 1999 Aug; 66(2):185-92. PubMed ID: 10460072
[TBL] [Abstract][Full Text] [Related]
11. Detection of CYP2D6*3 and 2D6*4 allelic variants by PCR-restriction fragment length polymorphism.
Topić E; Stefanović M; Nikolić V; Zoricić I; Ivanisević AM; Zuntar I
Clin Chem Lab Med; 1998 Aug; 36(8):655-8. PubMed ID: 9806480
[TBL] [Abstract][Full Text] [Related]
12. Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.
Gaedigk A; Bradford LD; Marcucci KA; Leeder JS
Clin Pharmacol Ther; 2002 Jul; 72(1):76-89. PubMed ID: 12152006
[TBL] [Abstract][Full Text] [Related]
13. Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
Arneth B; Shams M; Hiemke C; Härtter S
Clin Biochem; 2009 Aug; 42(12):1282-90. PubMed ID: 19393232
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of common cytochrome P450 2D6 alleles in Caucasians.
Roberts RL; Kennedy MA
Clin Chim Acta; 2006 Apr; 366(1-2):348-51. PubMed ID: 16364273
[TBL] [Abstract][Full Text] [Related]
15. Accurate determination of the CYP2D6 (*1/*4)xN genotype by quantitative PCR.
Pondman KM; van Schaik RHN; van der Weide J
Drug Metab Pers Ther; 2018 Mar; 33(1):33-39. PubMed ID: 29420304
[TBL] [Abstract][Full Text] [Related]
16. Rapid and comprehensive determination of cytochrome P450 CYP2D6 poor metabolizer genotypes by multiplex polymerase chain reaction.
Roberts R; Joyce P; Kennedy MA
Hum Mutat; 2000; 16(1):77-85. PubMed ID: 10874309
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
Gaikovitch EA; Cascorbi I; Mrozikiewicz PM; Brockmöller J; Frötschl R; Köpke K; Gerloff T; Chernov JN; Roots I
Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168
[TBL] [Abstract][Full Text] [Related]
18. Rapid and reliable method for cytochrome P450 2D6 genotyping.
Stamer UM; Bayerer B; Wolf S; Hoeft A; Stüber F
Clin Chem; 2002 Sep; 48(9):1412-7. PubMed ID: 12194916
[TBL] [Abstract][Full Text] [Related]
19. Genotyping CYP2D6 by three different methods: advantages and disadvantages.
Ribeiro C; Martins P; Grazina M
Drug Metab Pers Ther; 2017 Mar; 32(1):33-37. PubMed ID: 28170339
[TBL] [Abstract][Full Text] [Related]
20. Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes.
Gundry CN; Vandersteen JG; Reed GH; Pryor RJ; Chen J; Wittwer CT
Clin Chem; 2003 Mar; 49(3):396-406. PubMed ID: 12600951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
